markets

Magnificent Seven Stocks Are Lagging in 2025: One to Buy, One to Skip

Summarized from Yahoo

Five of the Magnificent Seven are trailing the broader market this year. Here's which one deserves your money and which one you should dodge.

The Magnificent Seven trade has lost its magic in 2025. Five of the seven mega-cap tech darlings are underperforming the market, and if you're still holding all of them equally, you're likely leaving money on the table — or worse, bleeding it.

The group that once looked bulletproof now looks fractured. Rising rates, valuation gravity, and shifting AI spending narratives have hit some names harder than others. Two stocks in particular stand out for opposite reasons — one is actually worth doubling down on, and one deserves a hard pass until the story changes.

Read more CoreWeave Stock Surges on Fresh AI Infrastructure Spending Boost →

The case for loading up comes down to business direction. One of the laggards has a clear, defensible path forward — its core business model is evolving in a way that justifies the current dip as a buying opportunity rather than a warning sign. When fundamentals are intact and the market is simply repricing sentiment, that's your entry window.

The one to avoid is a different story. Similar surface-level issues — slowing growth, margin pressure, macro headwinds — but without the same directional clarity. When you can't see where a company is steering, the risk-reward just doesn't work in your favor. Patience isn't a loss; it's capital preservation.

Bottom line: the Magnificent Seven isn't a monolith anymore. Treat it like a stock picker's market inside a basket trade. Know what you own and why. Continue reading at Yahoo.

Frequently Asked Questions

Q.How many Magnificent Seven stocks are underperforming the market in 2025?

Five of the seven Magnificent Seven stocks are underperforming the broader market so far in 2025, with only two managing to outpace it.

Q.Why are most Magnificent Seven stocks trailing the market this year?

The article points to similar issues across the group, including challenges tied to business direction and execution, though the specifics vary by company.

Q.What makes one Magnificent Seven stock worth buying while another should be avoided?

The stock worth buying has a clearer, more defensible business direction that justifies its underperformance as temporary. The one to avoid shares similar problems but lacks that same forward clarity.

More in markets →